Taligen Therapeutics Headquarters
The links below provide all the necessary information about Taligen Therapeutics Headquarters. Also there you will find information about the address, phone numbers, emails and much more.
Taligen Therapeutics - Crunchbase Company Profile
- https://www.crunchbase.com/organization/taligen-therapeutics
- none
Taligen Therapeutics, Inc. - Relationship Science
- https://relationshipscience.com/organization/taligen-therapeutics-inc-131177
- Headquarters 245 1st Street,Suite 1100,Cambridge, MA 02142 Type of Company Private Industries Pharmaceuticals Medical Support Services Company Description Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway.
Taligen Therapeutics Company Profile: Acquisition
- https://pitchbook.com/profiles/company/14143-06
- The company is developing therapies that regulate the complement system to treat inflammatory and immune diseases. Contact Information Website www.taligentherapeutics.com Ownership Status Acquired/Merged Financing Status Formerly VC-backed Primary Industry Drug Discovery Acquirer Alexion Primary Office Cambridge, MA United States
TALIGEN THERAPEUTICS, INC. | SBIR.gov
- https://www.sbir.gov/node/325829
- The Use of Complement Inhibitors as therapeutic agents in AMD. Amount: $175,065.00. DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the leading cause of blindness for Americans 60 years of age and older. It is estimated that the prevalence of AMD in the ... SBIR Phase I 2006 Department of Health and Human Services ...
Taligen names new CEO, establishes headquarters
- https://www.pharmaceutical-business-review.com/news/0f4aftaligen_names_new_ceo_establishes_headqua/
- Under Dr Celniker’s leadership, Taligen intends to build its late-stage R&D operations in Cambridge while maintaining in Denver its …
Working At Taligen Therapeutics: Employee Reviews and Culture
- https://www.zippia.com/taligen-therapeutics-careers-1407146/
- Learn about working at Taligen Therapeutics from employee reviews and detailed data on culture, salaries, demographics, management, financials, and more. Find out what it's like to work at Taligen Therapeutics. See what kind of people work at Taligen Therapeutics, career paths working at Taligen Therapeutics, company culture, salaries, employee ...
Taligen Therapeutics Initiates Corporate Growth Plan with …
- https://www.biospace.com/article/releases/taligen-therapeutics-initiates-corporate-growth-plan-with-appointment-of-b-abbie-celniker-ph-d-b-as-ceo-/
- CAMBRIDGE, Mass., July 23 /PRNewswire/ -- Taligen Therapeutics Inc. today announced it has initiated a corporate growth plan with the appointment of Abbie Celniker, Ph.D., as chief executive officer and the establishment of its headquarters in Cambridge, Mass. Dr. Celniker succeeds Woodruff Emlen, M.D., a co-founder of the company who remains president.
Alexion Acquires Taligen Therapeutics and Creates Translational ...
- https://ir.alexion.com/news-releases/news-release-details/alexion-acquires-taligen-therapeutics-and-creates-translational
- Taligen's scientific staff will form the nucleus of Alexion's new Cambridge Massachusetts -based Translational Medicine Group, headed by Abbie Celniker, Ph.D., former CEO of Taligen and now Head of Translational Medicine at Alexion. Dr.
Alexion Acquires Taligen Therapeutics and Creates Translational ...
- https://www.fiercebiotech.com/biotech/alexion-acquires-taligen-therapeutics-and-creates-translational-medicine-group-to
- CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. announced that it has acquired Taligen Therapeutics, Inc., a privately held development-stage biotechnology company based in Cambridge,
Taligen Pockets $10M to Move Candidate for Autoimmune …
- https://www.genengnews.com/news/taligen-pockets-10m-to-move-candidate-for-autoimmune-diseases-into-the-clinic/
- Founded in 2004, Taligen maintains its headquarters in Cambridge, MA. The company’s protein therapeutics are designed to selectively identify, target, and concentrate on inflammatory tissues....
Taligen Therapeutics Employee Details, Technology Stack and …
- https://www.slintel.com/company/taligen-therapeutics/5c3b003bd55ae49f1b762e92
- Find useful insights on Taligen Therapeutics’s employee, technology stack, location, news alerts and more at Slintel. Use Slintel to connect with top decision-makers at Taligen Therapeutics.
ALEXION PHARM : Alexion Acquires Taligen Therapeutics and …
- https://www.marketscreener.com/quote/stock/ALEXION-PHARMACEUTICALS-8334/news/ALEXION-PHARM-Alexion-Acquires-Taligen-Therapeutics-and-Creates-Translational-Medicine-Group-to-Ac-13548730/
- Alexion Pharmaceuticals, Inc. announced that it has acquired Taligen Therapeutics, Inc., a privately held development-stage biotechnology company based in Cambridge, Mass.
Taligen Therapeutics Calls Down $10 Million - Venture Capital …
- https://www.venturecapitaljournal.com/taligen-therapeutics-calls-down-10-million/
- Taligen Therapeutics Inc., an Aurora, Colo.-based drug company focused on modulation and control of the compliment system, has called down a $10 million, milestne-based tranche of its Series B funding round. The company secured $65 million for the round in 2008, and so far has called down around $36 million. Backers include Alta Partners, Clarus Ventures, …
Taligen Therapeutics Closes $10 Million Series B Financing
- https://www.biospace.com/article/releases/taligen-therapeutics-closes-10-million-series-b-financing-tranche-/
- Taligen’s targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. For additional information about the Company, please visit www.taligentherapeutics.com.
Did you find out everything you wanted about Taligen Therapeutics Headquarters?
We are sure that the information collected for you about Taligen Therapeutics Headquarters turned out to be more than enough.
